Recently Updated
- 12/15/2009
- Medical Abortion Guidebook
- 11/05/2009
- List of Mifepristone Approval
- 11/04/2009
- Map of Mifepristone Approval
- 05/25/2009
- Clinical Studies List
- 05/04/2009
- Medical Abortion Program Brief
Resources by Last Update
2009
December
November
May
Medical Abortion Program Brief
Pregnancy Failure and Miscarriage Program Brief
March
Fever after treatment of postpartum hemorrhage
Blood Loss After Vaginal Delivery
Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials
2008
July
Annotated Bibliography - Misoprostol for Early Abortion
June
Reference List - Misoprostol for Incomplete Abortion and Miscarriage
Policy and Advocacy Activities Brief
Misoprostol for Incomplete Abortion and Miscarriage
2007
February
PPH Misoprostol Adjunct Treatment Study
Misoprostol for Early Abortion
Medical Abortion in the U.S.: Mifepristone Fact Sheet
Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan
Treatment of incomplete abortion and miscarriage with misoprostol
Misoprostol to treat missed abortion in the first trimester
Supervision for use of mifepristone medical abortion
Misoprostol and Teratogenicity: Reviewing the Evidence
Misoprostol for Prevention of Postpartum Hemorrhage
Reference List - Misoprostol for Prevention of Postpartum Hemorrhage
Postpartum Hemorrhage: A Challenge for Safe Motherhood
Postpartum Hemorrhage: Responding to the Challenge
Misoprostol PPH Treatment Study
PPH Prevention Study in Pakistan
PPH Treatment Study in Pakistan
Misoprostol: A New Addition to Post Abortion Care
PAC in Action Newsletter: Special Issue on Misoprostol in the PAC Context
Relationship of Hormonal Contraception to HIV
FAQ on Hormonal Contraception and HIV
Issue Brief on Hormonal Contraception and HIV
Outlook Newsletter on Hormonal Contraception and HIV
FAQs on Fatal Infection and Medical Abortion - Technical Version
FAQs on Fatal Infection and Medical Abortion - Summary
Misoprostol for Women’s Health
Route of Misoprostol Administration
Treatment of postpartum hemorrhage with misoprostol
Prevention of postpartum hemorrhage with misoprostol
Reproductive intentions among HIV-positive women and men
Misoprostol for incomplete abortion in Tanzania
Misoprostol for incomplete abortion in Burkina Faso
Perspectives on reproductive decision-making amongst HIV-infected individuals
Misoprostol for incomplete abortion in Mozambique
The supreme court and the partial-birth abortion ban act of 2003
Methotrexate compared to misoprostol alone for early medical abortion
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Mifepristone for late first trimester abortion
Can mifepristone medical abortion be simplified?
Are two doses of misoprostol after mifepristone for early abortion better than one?
Alternatives to mifepristone for early medical abortion
Use of sequential serum hCG and sonography for medical abortion only when indicated
Misoprostol for uterine evacuation in induced abortion and pregnancy failure
Postpartum Hemorrhage Program Brief
Materials Development Activities Brief
Social Science Research Activities Brief
Technical Assistance Activities Brief
Training and Education Activities Brief
STIs/ HIV/ Infectious Disease Program Brief
Reference List - Misoprostol for Early Abortion
Abortion in the Middle East and North Africa
Choices for Medical Abortion Introduction in Brazil, Colombia, Mexico and Peru
Comment on Misoprostol impairs female reproductive tract innate immunity against C. sordellii
Expanding Choice in Abortion Services in Armenia
Two distinct oral routes of misoprostol in mifepristone medical abortion
Integrating medical abortion into safe abortion services in South Africa
Community-based kangaroo mother care to prevent neonatal and infant mortality
Clostridium sordellii infection in medical abortion
Regimens of misoprostol with mifepristone for early medical abortion
Abortion and sex determination
Improving Current Therapies and Exploring New Options in Abortifacient Technology
Mifepristone medical abortion in Albania
Sublingual misoprostol after mifepristone
Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan
Sublingual misoprostol for incomplete abortion
Increasing women’s choices in medical abortion in Turkey
Non-physician clinicians can safely provide first trimester medical abortion
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Guidebook on Misoprostol for Treatment of Incomplete Abortion
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1 of 2
Comparison of serum markers for thrombophilia and autoimmune disease
Knowledge, attitudes, and practice of abortion among women and doctors in Armenia
Acceptability and feasibility of medical abortion in Nepal
Annotated Bibliography - Mifepristone Medical Abortion
Home administration of misoprostol for early medical abortion in India
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2 of 2
Alternatives to Routine Follow-Up for Early Medical Abortion